ClinicalTrials.govpublic full text
Reducing Inflammation to Improve Vascular and Bone Outcomes With Low-dose Colchicine in CKD
chronic kidney disease mineral and bone disorder, hypertension, diabetes, dyslipidemia, atherosclerotic cardiovascular disease (ascvd), chronic kidney disease (stage 3)
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 373697
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.